Comparative Metabolomic Profiling and Gastroprotective Efficacy of Phoenix dactylifera L. Seed Extracts: Modulation of the Oxido-Inflammo-Apoptotic Axis in Gastric Ulcer Model
摘要
Phoenix dactylifera L. seeds (PDS) are traditionally used to treat gastric ailments. This study evaluated the gastroprotective effects of PDS (Sewy variety) extracts polar (70% aqueous methanol) and non-polar (n-hexane)) against ethanol-induced gastric ulcers and characterized their chemical complexity using advanced metabolomics.
MethodsThirty Wistar rats were allocated into five groups: normal, control (ethanol-treated rats), standard (Omeprazole, 20 mg/kg, orally), polar PDS (30 mg/kg, orally), and non-polar PDS (30 mg/kg, orally). To induce gastric ulcer, 1mL/kg of ethanol was given orally at the 7th day to rats. The extracts and reference drug were pretreated for 7 consecutive days. Gastric tissue oxidative stress markers (catalase, nitric oxide, myeloperoxidase), inflammatory mediators (TLR4, p-NF-κBP65, TNFα), mucosal integrity markers (HSP70, PGE2, hydroxyproline, gastrin, EGF, BAX/BCL2 ratio), and mucus secretion were assessed. Untargeted metabolomic profiling was performed via LC-ESI-MS/MS (ESI+) integrated with GNPS2 molecular networking.
ResultsBoth polar and non-polar PDS extracts significantly reduced oxidative stress and inflammatory mediators, and improved mucosal integrity compared to the ethanol-control group (p < 0.001 for HSP70 and PGE2). Hydroxyproline, gastrin, EGF, BAX/BCL2 levels, and mucus secretion were significantly enhanced. The non-polar extract exhibited superior activity. LC-MS/MS identified 44 metabolites, including phenolic acids, flavonoids, and glycerophospholipids. GNPS2 networking provided a structural map of the seed’s metabolites.
ConclusionsPDS extracts demonstrated a significant gastroprotection by modulating the oxido-inflammo-apoptotic response and enhancing mucosal healing. This activity is attributed to a rich chemical landscape of phenolics and phospholipids, supporting the traditional use of PDS as a therapeutic agent for gastric ulcers.
Graphical Abstract